Pharmacokinetics and preliminary safety of single-dose oral fluralaner at 10 and 25 mg/kg in healthy horses revealed no adverse reactions
Fluralaner's persistence in skin and plasma after oral administration has potential as a treatment for select ectoparasites in the horse, although further study is needed to determine the appropriate dose and dose interval.
Authors
- Jessica M. Morgan (ORCID: https://orcid.org/0000-0002-5935-8344)
- Stephen D. White (ORCID: https://orcid.org/0000-0003-3103-6930)
- Morgan Lehman (ORCID: https://orcid.org/0000-0001-7999-8704)
- Heather K. Knych (ORCID: https://orcid.org/0000-0002-8676-4970)
- Jennifer M. Cassano (ORCID: https://orcid.org/0000-0001-9093-5106)
- Samantha R. Gentille
- Anders Boss (ORCID: https://orcid.org/0000-0002-8575-5175)
- Francesca D. Goyette
Institutions
- Veterinary Medical Teaching Hospital (US)
- University of California, Davis (US)
Publication Details
- Journal
- American Journal of Veterinary Research
- Published
- 2025-10-03
- DOI
- https://doi.org/10.2460/ajvr.25.06.0200
- Primary Topic
- Insect and Pesticide Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00